Evidence map›Paper›PMID 35675226›Full record

ArticlePharmaceutical biology2022

Ethanol extract of the mushroom

Nuniek Ina Ratnaningtyas, Hernayanti Hernayanti, Nuraeni Ekowati, Fajar Husen

Abstract read
In one paragraph

Article in Pharmaceutical biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. In Vivo Regenerative Potential ofMolecules (Basel, Switzerland) · 2025
    Article
  4. Therapeutic potential ofVeterinary world · 2025
    Article
  5. Review
  6. Review
  7. Observational
  8. Article
  9. Probing the Therapeutic Efficacy ofBioinformatics and biology insights · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nuniek Ina RatnaningtyasDepartment of Biology, Faculty of Biology, Jenderal Soedirman University, Central Java, Indonesia.ORCID 0000-0002-7841-1999
Hernayanti HernayantiDepartment of Biology, Faculty of Biology, Jenderal Soedirman University, Central Java, Indonesia.ORCID 0000-0002-3468-7563
Nuraeni EkowatiDepartment of Biology, Faculty of Biology, Jenderal Soedirman University, Central Java, Indonesia.ORCID 0000-0002-5927-0967
Fajar HusenDepartment of Medical Laboratory of Technology, Bina Cipta Husada College of Health Science, Central Java, Indonesia.ORCID 0000-0003-3278-4711

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextEdible mushrooms have a long history of use in traditional Chinese or Japanese medicine.

objectiveTo identify the benefits of ethanol extracts of the MATERIALS AND

methodsWistar rats were either left untreated or were administered 45 mg/kg body weight (BW) streptozotocin; 45 mg/kg BW metformin; or 250, 500, or 750 mg/kg BW extract for 14 days. The blood glucose, GLP-1, DPP-4, GSH, insulin, and HbA1c levels were determined. Data were analysed using analysis of variance and Duncan's multiple range tests.

resultsPreliminary data showed that administration of

conclusionsThe

Indexed as

AntioxidantsCoprinusDiabetes Mellitus, ExperimentalHypoglycemic AgentsAnimalsBlood GlucoseEthanolGlucagon-Like Peptide 1Glycated HemoglobinInsulinRatsRats, WistarStreptozocinAntioxidantsBlood GlucoseEthanolGlucagon-Like Peptide 1Glycated HemoglobinHypoglycemic AgentsInsulinStreptozocinBioactive compoundsdiabetes mellitusDPP-4GLP-1reactive oxygen species

Identifiers

PMID35675226
PMCPMC9186368

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.